Santa Cruz and colleagues established IL-6 as a biomarker for developing Fatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pneumonia due to its positive correlation with C-reactive protein (CRP) and respiratory failure. Here, CRP is linked to respiratory failure.